ESALY - Eisai Co. Ltd. (ESALF) CEO Haruo Naito on Q4 2019 Results - Earnings Call Transcript
Eisai Co., Ltd. (ESALF)
Q4 2019 Earnings Conference Call
May 13, 2020 3:30 AM ET
Company Participants
Haruo Naito - Representative Director and Chief Executive Officer
Ivan Cheung - Senior Vice President and President, Neurology Business Group
Takashi Owa - Vice President, Chief Medicine Creation Officer and Chief Discovery Officer, Oncology Business Group
Conference Call Participants
Hidemaru Yamaguchi - Citigroup Securities
Kazuaki Hashiguchi - Daiwa Securities
Fumiyoshi Sakai - Credit Suisse Securities
Presentation
Operator
At this time we would like to begin Financial Results Presentation on Fiscal 2019 Results. Because of COVID-19 infection situation, today